126 related articles for article (PubMed ID: 10926322)
1. Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes.
Niskanen L; Voutilainen-Kaunisto R; Teräsvirta M; Karvonen MK; Valve R; Pesonen U; Laakso M; Uusitupa MI; Koulu M
Exp Clin Endocrinol Diabetes; 2000; 108(3):235-6. PubMed ID: 10926322
[TBL] [Abstract][Full Text] [Related]
2. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
Niskanen L; Karvonen MK; Valve R; Koulu M; Pesonen U; Mercuri M; Rauramaa R; Töyry J; Laakso M; Uusitupa MI
J Clin Endocrinol Metab; 2000 Jun; 85(6):2266-9. PubMed ID: 10852461
[TBL] [Abstract][Full Text] [Related]
3. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients.
Pettersson-Fernholm K; Karvonen MK; Kallio J; Forsblom CM; Koulu M; Pesonen U; Fagerudd JA; Groop PH;
Diabetes Care; 2004 Feb; 27(2):503-9. PubMed ID: 14747236
[TBL] [Abstract][Full Text] [Related]
4. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.
Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562
[TBL] [Abstract][Full Text] [Related]
5. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
[TBL] [Abstract][Full Text] [Related]
6. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
Pesonen U; Koch W; Schömig A; Kastrati A
J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169
[TBL] [Abstract][Full Text] [Related]
7. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
Ukkola O; Kesäniemi YA
Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.
Jaakkola U; Koulu M; Karvonen MK; Seppälä H; Pesonen U; Vahlberg T; Kallio J
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):281-6. PubMed ID: 17516289
[TBL] [Abstract][Full Text] [Related]
9. The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy.
Jaakkola U; Pesonen U; Vainio-Jylhä E; Koulu M; Pöllönen M; Kallio J
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):147-52. PubMed ID: 16705546
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory effects of blood leukocytes: association with vascular function in neuropeptide Y proline 7-genotyped type 2 diabetes patients.
Kakko T; Jaakkola U; Raitakari OT; Kallio J
Diab Vasc Dis Res; 2011 Jul; 8(3):221-8. PubMed ID: 21746772
[TBL] [Abstract][Full Text] [Related]
11. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
Karvonen MK; Valkonen VP; Lakka TA; Salonen R; Koulu M; Pesonen U; Tuomainen TP; Kauhanen J; Nyyssönen K; Lakka HM; Uusitupa MI; Salonen JT
Atherosclerosis; 2001 Nov; 159(1):145-51. PubMed ID: 11689216
[TBL] [Abstract][Full Text] [Related]
12. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes.
Jaakkola U; Kakko T; Seppälä H; Vainio-Jylhä E; Vahlberg T; Raitakari OT; Kallio J
Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.
Ilveskoski E; Viiri LE; Mikkelsson J; Pörsti I; Lehtimäki T; Karhunen PJ
Atherosclerosis; 2008 Aug; 199(2):445-50. PubMed ID: 18054939
[TBL] [Abstract][Full Text] [Related]
14. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY.
Kallio J; Pesonen U; Karvonen MK; Kojima M; Hosoda H; Kangawa K; Koulu M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5348-52. PubMed ID: 11701704
[TBL] [Abstract][Full Text] [Related]
15. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI
Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038
[TBL] [Abstract][Full Text] [Related]
16. The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
Jaakkola U; Kuusela T; Jartti T; Pesonen U; Koulu M; Vahlberg T; Kallio J
J Clin Endocrinol Metab; 2005 Jun; 90(6):3646-52. PubMed ID: 15797951
[TBL] [Abstract][Full Text] [Related]
17. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415
[TBL] [Abstract][Full Text] [Related]
18. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
[TBL] [Abstract][Full Text] [Related]
19. Leucine 7-proline 7 polymorphism in the signal peptide of neuropeptide Y is not a risk factor for exudative age-related macular degeneration.
Kaarniranta K; Holopainen JM; Karvonen MK; Koulu M; Kallio J; Pesonen U; Teräsvirta M; Uusitalo H; Immonen I
Acta Ophthalmol Scand; 2007 Mar; 85(2):188-91. PubMed ID: 17305733
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization.
Koulu M; Movafagh S; Tuohimaa J; Jaakkola U; Kallio J; Pesonen U; Geng Y; Karvonen MK; Vainio-Jylhä E; Pöllönen M; Kaipio-Salmi K; Seppälä H; Lee EW; Higgins RD; Zukowska Z
Ann Med; 2004; 36(3):232-40. PubMed ID: 15181979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
